Cardiff Oncology, Inc. (CRDF)
Nasdaq: CRDF · CIK 0001213037 · United States
Every official Cardiff Oncology, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CRDF filings
Cardiff Oncology, Inc. documents
- Cardiff Oncology, Inc. 10-K 2026CRDF 10-K 2026: annual report for fiscal 2026
- Cardiff Oncology, Inc. 10-K 2025CRDF 10-K 2025: annual report for fiscal 2025
- Cardiff Oncology, Inc. 10-K 2024CRDF 10-K 2024: annual report for fiscal 2024
- Cardiff Oncology, Inc. 10-K 2023CRDF 10-K 2023: annual report for fiscal 2023
- Cardiff Oncology, Inc. 10-K 2022CRDF 10-K 2022: annual report for fiscal 2022
- Cardiff Oncology, Inc. 10-Q 2026CRDF 10-Q 2026: quarterly report for fiscal 2026
- Cardiff Oncology, Inc. 10-Q 2025CRDF 10-Q 2025: quarterly report for fiscal 2025
- Cardiff Oncology, Inc. 10-Q 2024CRDF 10-Q 2024: quarterly report for fiscal 2024
- Cardiff Oncology, Inc. 10-Q 2023CRDF 10-Q 2023: quarterly report for fiscal 2023
- Cardiff Oncology, Inc. 10-Q 2022CRDF 10-Q 2022: quarterly report for fiscal 2022
- Cardiff Oncology, Inc. 8-K 2026CRDF 8-K 2026: current report for fiscal 2026
- Cardiff Oncology, Inc. 8-K 2025CRDF 8-K 2025: current report for fiscal 2025
- Cardiff Oncology, Inc. 8-K 2024CRDF 8-K 2024: current report for fiscal 2024
- Cardiff Oncology, Inc. 8-K 2023CRDF 8-K 2023: current report for fiscal 2023
- Cardiff Oncology, Inc. 8-K 2022CRDF 8-K 2022: current report for fiscal 2022
- Cardiff Oncology, Inc. DEF 14A 2026CRDF DEF 14A 2026: proxy statement for fiscal 2026
- Cardiff Oncology, Inc. DEF 14A 2025CRDF DEF 14A 2025: proxy statement for fiscal 2025
- Cardiff Oncology, Inc. DEF 14A 2024CRDF DEF 14A 2024: proxy statement for fiscal 2024
- Cardiff Oncology, Inc. DEF 14A 2023CRDF DEF 14A 2023: proxy statement for fiscal 2023
- Cardiff Oncology, Inc. DEF 14A 2022CRDF DEF 14A 2022: proxy statement for fiscal 2022
- Cardiff Oncology, Inc. Form 4 2026CRDF Form 4 2026: insider trading filing for fiscal 2026
- Cardiff Oncology, Inc. Form 4 2025CRDF Form 4 2025: insider trading filing for fiscal 2025
- Cardiff Oncology, Inc. Form 4 2024CRDF Form 4 2024: insider trading filing for fiscal 2024
- Cardiff Oncology, Inc. Form 4 2023CRDF Form 4 2023: insider trading filing for fiscal 2023
- Cardiff Oncology, Inc. Form 4 2022CRDF Form 4 2022: insider trading filing for fiscal 2022
- Cardiff Oncology, Inc. S-1 2026CRDF S-1 2026: registration statement for fiscal 2026
- Cardiff Oncology, Inc. S-1 2025CRDF S-1 2025: registration statement for fiscal 2025
- Cardiff Oncology, Inc. S-1 2024CRDF S-1 2024: registration statement for fiscal 2024
- Cardiff Oncology, Inc. S-1 2023CRDF S-1 2023: registration statement for fiscal 2023
- Cardiff Oncology, Inc. S-1 2022CRDF S-1 2022: registration statement for fiscal 2022
- Cardiff Oncology, Inc. 13F 2026CRDF 13F 2026: institutional holdings for fiscal 2026
- Cardiff Oncology, Inc. 13F 2025CRDF 13F 2025: institutional holdings for fiscal 2025
- Cardiff Oncology, Inc. 13F 2024CRDF 13F 2024: institutional holdings for fiscal 2024
- Cardiff Oncology, Inc. 13F 2023CRDF 13F 2023: institutional holdings for fiscal 2023
- Cardiff Oncology, Inc. 13F 2022CRDF 13F 2022: institutional holdings for fiscal 2022
More companies